When does an app need FDA’s blessing?
Some apps help people look up symptoms, check drug side effects or locate. Some even measure blood pressure and blood sugar and send the readings off to the doctor. As a result, the Food and Drug Administration has concluded that at least some apps should undergo review by the agency before being permitted on the market. Dr. Jeffrey Shuren, who heads the FDA's Center for Devices and Radiological Health, stresses that the FDA has no plans to review most apps, such as those that help with wellness, healthier lifestyles. Same goes for those used to help patients manage their medical conditions. "The risk to patients are very, very low," he says.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- mHealth Tackles Readmissions
- Proton Beam Therapy Poised for Growth in US
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'